PQA

Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System

Product code
PQA
Device name
Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
Device class
Class 2
21 CFR
21 CFR 866.3975
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
4
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
12 (all years; only the last 3 years are listed here)

FDA classification definition

A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (4)

Last three years. Most recent: 2026-07-16.

NumberDecision dateApplicantDevice nameSummary
K2600212026-07-16Roche Molecular Systems, Inc.cobas® BV/CVPDF
K2437252024-12-19Becton, Dickinson and CompanyBD Vaginal PanelFDA
K2433452024-11-25Hologic, Inc.Aptima BV Assay; Aptima CV/TV AssayPDF
K2313812023-10-19CepheidXpert Xpress MVP; GeneXpert Xpress SystemPDF

3 summaries are archived here for direct download.

Official FDA classification page: PQA
Classification and pathway per current FDA publications. Data from openFDA (CC0).